Generic Substitution Archives

Generic drugmakers to sell Pfizer’s Paxlovid for $25 or less in low-income countries

Clinton Health Access Initiative (CHAI), COVID-19 Therapeutic, COVID-19 Therapeutics, COVID-19 Therapies, Drug Pricing, Generic Substitution, Generics, Low-Income Countries, Medicines Patent Pool, Middle-Income Countries, Pfizer, Therapeutics, United Nations

Several generic drugmakers that will produce versions of Pfizer’s COVID-19 antiviral treatment Paxlovid agreed to sell the medicine in low-income and middle-income countries for $25 a course or less, the Clinton Health Access Initiative (CHAI) said on May 12.

May 12, 2022/by Reuters Health

U.S. Congress Proposes Bills to Strengthen Pharma Competition, Promote Innovation

Authorized Generics, Biosimilars, Branded Generics, Clinical Trials, Congress, Drug Price Reform, Drug Prices, Drug Pricing, Generic Substitution, Generics, House Committee on Oversight and Government Reform, Interchangeable Biosimilars, Pricing, R&D, R&D Investment Return

On Thursday, members of both the U.S. House of Representatives and the U.S. Senate introduced legislation that targets efforts that have limited competition, which keeps the price of prescription drugs high.

April 8, 2022/by BioSpace